South Africa has received its first consignment of lenacapavir, a twice-a-year anti-HIV injection, which arrived from Dublin six weeks later than anticipated.

Eswatini, a southern African country with the world's highest HIV prevalence, is receiving insufficient amounts of lenacapavir, a drug that could significantly reduce new HIV infections.

Nigeria's health agency has issued a warning to pregnant women against using the new long-acting Lenacapavir HIV injection, citing insufficient safety data for this demographic.

Nigerians are seeking Lenacapavir, a new anti-HIV injection for prevention. Learn about the high demand, government rollout, and how this PrEP drug works. Read More:…

Every year, millions of people become newly infected with HIV.

Kenya's health authorities have started offering lenacapavir, a long-acting HIV prevention drug administered by injection, free of charge to eligible patients, providing protection for six months.

The United States and the Global Fund have set a goal to provide lenacapavir, an HIV treatment, to 3 million beneficiaries by 2028. This initiative aims to significantly expand access to critical HIV medication globally.

Eswatini (formerly Swaziland) has begun administering lenacapavir, a breakthrough injectable drug, with health authorities hoping to end the HIV/AIDS epidemic in the country by 2030.

A charity reports that Kenya's rollout of the "breakthrough" HIV prevention drug lenacapavir is failing to reach the most vulnerable populations who need it most.

Nigeria has begun rolling out Lenacapavir, a long-acting injectable drug for HIV prevention, with 52,000 doses arriving as part of its goal to end AIDS by 2030, though the health agency has warned against its use in pregnant women due to insufficient safety data.

Nigeria has taken a major step in its fight against HIV with the arrival of the first tranche of lenacapavir, a long-acting injectable drug expected to transform HIV prevention and accelerate…

Nigeria's Federal Government has confirmed that Lenacapavir, a breakthrough HIV prevention injection, will arrive in March. This twice-yearly PrEP drug has shown 100% effectiveness.

A new study has found that to escape a drug called lenacapavir, HIV has to damage one of its own components, the capsid. The finding reaffirmed the belief that the viral capsid is a good drug target and that the virus can’t afford to change it too much, opening the door to a new generation of drugs

The new HIV injection, Lenacapavir, faces a slow rollout in Abuja due to limited doses and significant logistical challenges, according to officials.

Initial trials of lenacapavir, an injectable drug nearly equivalent to a vaccine for AIDS, are underway in Africa. Eswatini, with the world's highest HIV prevalence, is among the first countries to distribute the drug, with health authorities hoping it can end the epidemic.

An activist living with HIV argues that the UK's cuts to financial aid represent a betrayal of women and girls in sub-Saharan Africa, especially amidst medical breakthroughs like the HIV prevention drug Lenacapavir that require support.

South Africa is preparing to roll out the twice-a-year lenacapavir HIV prevention shot, with projections indicating a significant reduction in infections by 2045 if implemented swiftly.

Mr Ghebreyesus said a new medicine approved in 2025 for HIV prevention, Lenacapavir, represents the most significant development in combating HIV since the first antiretroviral treatments were…

No recklessness: State clarifies limits of new HIV prevention Lenacapavir  the-star.co.ke

Tanzania has officially registered Lenacapavir, a new drug, marking a significant advancement in the country's efforts for HIV prevention and treatment.